Canada Pension Plan Investment Board
AVDL

Canada Pension Plan Investment Board’s Avadel Pharmaceuticals AVDL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,500
Closed -$269K – 1708
2025
Q4 		$269K Buy
+12,500
New +$243K ﹤0.01% 1555

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Canada Pension Plan Investment Board's AVDL Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 12,500 shares — an estimated $269K sold.

Canada Pension Plan Investment Board first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $269K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 12,500 Avadel Pharmaceuticals shares in Q1 2026, an estimated $269K.
  • Canada Pension Plan Investment Board first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Avadel Pharmaceuticals position peaked at $269K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.